Labetalol Hydrochloride Injection
Product Images NDC 72266-103

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Labetalol Hydrochloride (NDC 72266-103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fosun Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Labetalol Carton)

This is a description of the medication Labetalol Hydrochloride in a 200 mg/40 mL (5mg/mL) injection solution for intravenous administration. The solution is contained in a multi-dose vial and is intended for use with a prescription (Rx only). The formulation also contains anhydrous dextrose and edetate disodium. Additional details including recommended dosage and storage instructions are provided on the package insert. The product is distributed by Fosun Pharma USA Inc. The trademark Novaplus belongs to Vizient, Inc.*

FDA Label Image

Labetalol Structural Formula (Labetalol Structural Formula)

FDA Label Image

Vial (Labetalol Vial)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.